Active11078106Private limited companyBurnley

SONIFAR PHARMA EXPERT LIMITED

Significant control: Songul Emritte (25–50%), Zohra Allimah Shadoobuccus (25–50%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Sonifar Pharma Expert Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Sonifar Pharma Expert Limited sell?

Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

SONIFAR PHARMA EXPERT LIMITED is an active private limited company (company number 11078106) incorporated on 23 November 2017, registered in Burnley. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 30 November 2025, showing net assets of £100 and cash of £100, with 0 employees on average. Net assets were unchanged on the prior period. Across the last 3 periods on record the net-asset trend is flat.

Peer position · net assets

By net assets it sits in the lower half of 307 comparable companies in the UK (median £1,000, upper quartile £146k).

02

Ownership and control

2 active · 1 other
  • Songul Emritte
    Individual · since 23 November 2017
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Ms Zohra Allimah Shadoobuccus
    Individual · since 20 June 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Nizam Mohamed Emritte
    Individual · since 23 November 2017 · ceased 20 June 2019
    • owns 50–75% of shares
    • holds 50–75% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
23 November 20178 yrs ago
Next accounts due
30 August 2027in 307 days
Confirmation statement due
7 December 2026in 41 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21200
Manufacture of pharmaceutical preparations
SIC 46180
Agents specialised in the sale of other particular products
SIC 46460
Wholesale of pharmaceutical goods
SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

3 periods on record · latest ending 30 November 2025
Net assets
£100
No changevs Nov 2024
Cash at bank
£100
No changevs Nov 2024
Turnover
Not reported
Employees
0
vs Nov 2024
Net assets
£100
Cash at bank
£100
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 November 2025£100£100————0
30 November 2024£100£100————0
30 November 2023£100£100————0

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £100 at 30 November 2025
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 23 November 2017

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 307 days
  2. Confirmation statement duein 41 days
  3. Accounts period endNet assets £100 · small accounts
  4. Accounts period endNet assets £100 · small accounts
  5. Accounts period endNet assets £100 · small accounts
  6. Incorporated
08

Similar companies in Lancashire

Same activity (manufacture of pharmaceutical preparations), closest in incorporation date
09

Reminders for SONIFAR PHARMA EXPERT LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.